Extracting high-quality genomic DNA (gDNA) from tissue is the first step for many molecular genetic studies and clinical diagnostic tests \[[@B1]\]. For rapid clinical genetic tests, such as qPCR, PCR-based genotyping and nanopore-based sequencing, the DNA extraction step is now the most time-consuming component of the workflow and adds significant time to the testing \[[@B1],[@B6]\]. Extraction of gDNA from mammalian tissue typically uses detergents and/or enzymes to lyse the cell and nuclear membranes, providing DNA yields of approximately 0.2--3 μg of gDNA per milligram of tissue, depending on the tissue \[[@B12]\]. However, the lysis step requires between 2 and 12 h to complete. Because incomplete lysis will lead to a decrease in DNA yield and an overnight lysis leads to higher gDNA yields without decreasing DNA quality \[[@B13],[@B14]\], the standard protocol for many basic and clinical labs is to use overnight lysis to ensure the quality and yield of gDNA extracted from mammalian tissues \[[@B5],[@B13],[@B15]\]. Liquid nitrogen and tissue disruption using a syringe have also been used to enhance the homogenization of human tissue samples and shorten lysis processing times to approximately 1 h \[[@B16],[@B17]\]. However, these methods require more hands-on time, have a low throughput and are not amenable to automation ([Figure 1](#F1){ref-type="fig"}). While traditional bead-bashing methods for DNA extraction have been applied to samples that are difficult to extract, such as insect cells \[[@B18]\], they have required the use of β-mercaptoethanol (β-ME), a fume hood and a more complex multi-step procedure using multiple DNA purification columns, which is impractical for use with automation and/or in a clinical setting ([Figure 1](#F1){ref-type="fig"}).

![Comparison of workflows between the manufacturer\'s lysis-based and bead bashing-based, and the rapid bead bashing-based protocol.\
Images of each module were adapted from manufacturer\'s protocols. **(A)** Workflow illustration remade from manufacturer\'s protocol in QIAamp DNA mini kit for tissue. **(B)** Workflow illustration remade from manufacturer\'s protocol in Quick-DNA Insect/Tissue kit. **(C)** Workflow illustration of rapid bead-bashing-based gDNA extraction methods reported in this study.](btn-68-240-g1){#F1}

In this study, we report a simplified bead-bashing-based (BBB) method for rapidly extracting high-quality gDNA from human tissue. This simplified workflow streamlines the gDNA extraction process and provides sufficient high-quality gDNA for in under 15 min. An enhanced workflow also provides more than triple the gDNA yield to accommodate applications requiring higher input DNA quantities.

Materials & methods {#S0001}
===================

gDNA was extracted from approximately 2 mg samples of chorionic villi. Tissues were weighed in an analytical scale (Mettler, AE 100), placed in ZR BashingBead Lysis Tubes (2.0 mm) (Zymo, D6015), and mixed with 550 μl BashingBead Buffer (Zymo, D6015) and 10 μl RNase A 20 mg/ml (Invitrogen, 12091021). Each sample was vortexed on a vortex mixer (Fisher, 02-215-422) at maximum speed (3000 rpm) for 7 min. Should faster treatment be needed, a high-speed cell disrupter such as FastPrep-24 (maximum speed 4750 rpm) or BeadRuptor 24 (maximum speed 5000 rpm) can be used to complete the homogenizing process in 3--5 min, as suggested by the manufacturer\'s protocol (Zymo, D6015), with optimization based on tissue type. Each homogenized sample was subjected to centrifugation at 12,000 rcf for 1 min (Eppendorf centrifuge 5424), and 200 μl supernatant was retrieved for column purification. This step allows the retrieval of approximately 0.4 μg DNA per mg tissue ([Figure 1](#F1){ref-type="fig"}).

Should additional gDNA be needed for downstream analysis, a 3-min extension may be used with an additional 200 μl bashing bead buffer added to each original ZR BashingBead lysis tube, vortexed for 30 s and the supernatant recovered as above. Should still more gDNA be needed, another 6-min extension may be used by repeating the additional 200 μl bashing bead buffer bead-bashing step. Total gDNA yields per sample represent the cumulative gDNA recovered from these elutions ([Supplementary Figure 1](https://www.future-science.com/doi/suppl/10.2144/btn-2019-0172/suppl_file/btn-68-240-s1.pdf)).

To perform column purification, supernatants were mixed with threefold volume of DNA Binding Buffer (Zymo, D4013) at room temperature (∼25°C), and then loaded on Zymo IC Spin columns (assembled in a clean 2 ml collection tube) (Zymo, D4013). Spin columns were centrifuged at 10,000 rcf for 30 s, then washed in first 500 μl and then 200 μl DNA Wash Buffer (Zymo, D4013) at 10,000 rcf for 30 s each. The columns containing ultrapure gDNA were then incubated with 40 μl Zymo DNA elution buffer (10 mM Tris-HCl, pH 8.5, 0.1 mM EDTA) (Zymo, D4013) at 37°C for 1--3 min, and then centrifuged at 10,000 rcf for 30 s in a clean low-retention microcentrifuge tube (1.5 ml).

The quality of gDNA was examined on a 0.8% agarose gel, and the concentration was determined by a Qubit dsDNA HS assay kit (Invitrogen, Q32851). A comparative study with the Zymo Quick-DNA™ Tissue/Insect kit (Zymo, D6015) was performed according to the manufacturer\'s protocol. The study was approved by the Columbia University Institutional Review Board.

Results & discussion {#S0002}
====================

The Quick-DNA™ Tissue/Insect Microprep Kit (Zymo, D6015) requires the use of β-ME, a fume hood, multiple columns and purification steps that increase hands-on time and make automation -- important for clinical application -- challenging ([Figure 1](#F1){ref-type="fig"}). We first tried omitting β-ME; however, this resulted in poor DNA quality ([Figure 2](#F2){ref-type="fig"}A). To optimize the purification of gDNA following bead bashing without the need for β-ME, we next compared the manufacturer\'s purification protocol with a direct DNA Clean & Concentrator-5 (Zymo, D4013) protocol. Compared with the manufacturer\'s protocol, the direct DNA Clean & Concentrator-5 protocol has fewer centrifugation steps (5 vs 7), a shorter centrifugation time (30 s vs 1 min), and overall requires less time than the kit\'s protocol (12 vs 17.5 min) ([Figure 1](#F1){ref-type="fig"} & [Supplementary Figure 1](https://www.future-science.com/doi/suppl/10.2144/btn-2019-0172/suppl_file/btn-68-240-s1.pdf)). It also only uses a single column (IC column vs III F filter + IC column) and one wash buffer (DNA Wash Buffer vs DNA Pre-Wash Buffer + gDNA Wash Buffer) ([Figure 1](#F1){ref-type="fig"}). The direct DNA Clean & Concentrator-5 protocol recovered a similar amount of gDNA as the original kit, but yielded larger fragments (\>15 kb) of intact gDNA instead of smeared DNA ([Figure 2](#F2){ref-type="fig"}A). Hence, the direct DNA Clean & Concentrator-5 is more suitable for purification of gDNA from human soft tissue in combination with a 7--8 min bead-bashing treatment. The Quick-DNA Tissue/insect kit uses the selective chemistry of different washing buffers to eliminate RNA, but this protocol is insufficient to remove impurities in gDNA from human soft tissues without the addition of β-ME ([Figure 2](#F2){ref-type="fig"}A). To eliminate these steps, we added RNase A during the bead-bashing step so that a simple DNA Clean & Concentrator-5 protocol with one DNA wash buffer is sufficient to yield clean intact gDNA ([Figure 1](#F1){ref-type="fig"} & [Figure 2](#F2){ref-type="fig"}A).

![Development of rapid bead bashing-based method and extensions.\
**(A)** Comparison of gDNA purified using two β-mercaptoethanol-free protocols by gel electrophoresis. Two tissue samples **(A & B)** were purified using the Quick-DNA insect/tissue kit protocol (Mfr) and DNA Clean & Concentrator-5 protocol (rapid). **(B)** Gel image of gDNA extracted from chronic villus tissue samples using the rapid and extended BBB protocols. Tissue samples (samples 1--4) were subjected to the rapid BBB method as well as a 3- and 6-min extension. **(C)** Evaluation of the impact of the bead-bashing process on the integrity of gDNA. Technical repeats of gDNA were treated for 3, 5 and 10 min bead bashing times. **(D)** gDNA yields using rapid and extended BBB methods. gDNA yields from each individual sample are shown by dots; the bar graph indicates the mean value ± SD.\
BBB: Bead bashing-based.](btn-68-240-g2){#F2}

We next tested the 12-min rapid, and 3- and 6-min extended BBB gDNA protocols on 34 chorionic villus tissue specimens ([Supplementary Table 1](https://www.future-science.com/doi/suppl/10.2144/btn-2019-0172/suppl_file/btn-68-240-s1.pdf)). gDNA quality was examined by gel electrophoresis ([Figure 2](#F2){ref-type="fig"}B). Using the 12-min rapid BBB protocol, 0.40 ± 0.17 μg (mean ± standard deviation) of gDNA were extracted per milligram of tissue (range: 0.11--0.77 μg per mg of tissue), sufficient for downstream applications such as qPCR, MLPA, microarray analysis and nanopore-based sequencing, and similar to gDNA yields using the manufacturer\'s protocol (1--3 μg gDNA per mg tissue) ([Figure 2](#F2){ref-type="fig"}D and [Supplementary Table 1](https://www.future-science.com/doi/suppl/10.2144/btn-2019-0172/suppl_file/btn-68-240-s1.pdf)). The 3- and 6-min extended protocols resulted in an additional 0.43 ± 0.23 μg (range: 0.08--1.05 μg) and 0.48 ± 0.43 μg (range: 0.16--2.45 μg) per milligram of tissue, respectively, sufficient yields for whole genome sequencing, genotyping and other downstream analysis ([Figure 2](#F2){ref-type="fig"}D & [Supplementary Table 1](https://www.future-science.com/doi/suppl/10.2144/btn-2019-0172/suppl_file/btn-68-240-s1.pdf)). In total, 0.4--3 μg gDNA were extracted per milligram of tissue samples using rapid BBB methods with the 6-min extensions, comparable with commercial kits such as QIAamp DNA Mini Kit (Qiagen, 51304: 0.2--3 μg per mg of tissue) and PureLink gDNA kit (Invitrogen, K182001: 0.4--4 μg per mg tissue).

Two nonsystemic factors can contribute to the large standard deviation of gDNA yields reported in this study. The first is the low DNA input. The suggested input of this method is 2--5 mg tissue, making it more sensitive to medium/buffer retention than a 20 mg tissue sample. Retention of 1 μl liquid will lead to an approximately 1 mg increase in estimated weight. Second, there was variation inherent in the samples. The method was performed on actual clinical samples and there may have been variability in the initial processing and handling of these samples that could impact their DNA yield. However, the gDNA yields across all samples were within the range of expected yield for the commercial kits, and sufficient for gDNA-based assay. In this study, sample 26 produced the lowest gDNA yield using the rapid and extended BBB methods. That could have been caused by an overestimation of the sample weight, or low amounts of genetic material in the initial specimen. However, even in this sample the gDNA yield was sufficient for nanopore sequencing or PCR-based assays.

Finally, we investigated the effect of the bead-bashing time on the integrity of large gDNA fragments in lieu of multi-hour lysis steps. gDNA (100 ng) in TE buffer was subjected to bead-bashing at 3000 rpm for 3, 5 and 10 min; examination of a 0.8% agarose gel confirmed that 10 min of the bead-bashing process did not result in an increased amount of sheared DNA ([Figure 2](#F2){ref-type="fig"}C).

The rapid BBB methods showed promising results for gDNA extraction from human soft tissue in under 20 min. The 12-min rapid BBB method yields sufficiently large fragment size (\>15 kb) gDNA for applications that require 100 ng gDNA or less \[[@B1],[@B6],[@B11]\]. The 3- and 6-min extensions recovered more gDNA from the same specimen to accommodate applications that requires sub-μg to μg-level gDNA input \[[@B5],[@B19]\]. The rapid BBB gDNA extraction method significantly reduces the time, complexity and equipment required to extract high-quality gDNA from tissue, and allows urgent gDNA-based diagnostic tests to be carried out in a timely manner. However, the BBB methods will need further validation and testing of different tissues.

The rapid BBB method can provide large-size gDNA from clinical human specimens in under 15 min, which can assist rapid gDNA-based clinical diagnostic assays and significantly shorten the workflow. The addition of a 3- or 6-min extension to the protocol can also provide sufficient gDNA for applications requiring higher input. Overall, this is a rapid yet efficient and versatile tissue gDNA extraction method for clinical and basic research.

Future perspective {#S0003}
==================

The clinical applications of rapid DNA-based diagnostic techniques such as qPCR, PCR-based genotyping, and nanopore sequencing have surged, and with them an increasing need for faster methods for extracting gDNA from tissue. The protracted time required for DNA extraction delays the turnaround time for many molecular assays, including urgent and time-sensitive applications where return of results in the same day or even within hours is of important clinical value. A simple, robust and rapid gDNA extraction method can significantly speed up rapid clinical diagnostics and make same-day results accessible.
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======================
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